1. Home
  2. BOLT vs BTTC Comparison

BOLT vs BTTC Comparison

Compare BOLT & BTTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bolt Biotherapeutics Inc.

BOLT

Bolt Biotherapeutics Inc.

HOLD

Current Price

$3.89

Market Cap

7.1M

Sector

Health Care

ML Signal

HOLD

BTTC

Black Titan Corporation Ordinary Shares

HOLD

Current Price

$0.52

Market Cap

8.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOLT
BTTC
Founded
2015
1990
Country
United States
Malaysia
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.1M
8.3M
IPO Year
2021
2024

Fundamental Metrics

Financial Performance
Metric
BOLT
BTTC
Price
$3.89
$0.52
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$34.00
N/A
AVG Volume (30 Days)
23.8K
583.9K
Earning Date
05-13-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,695,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$133.33
N/A
P/E Ratio
N/A
$2.22
Revenue Growth
0.07
N/A
52 Week Low
$3.13
$0.54
52 Week High
$7.20
$11.22

Technical Indicators

Market Signals
Indicator
BOLT
BTTC
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
BOLT
BTTC

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. The company is focused on the clinical development of BDC-4182, its claudin 18.2 ISAC. Its other pipeline programs include CEA ISAC program a Boltbody ISAC targeting carcinoembryonic antigen cell adhesion molecule 5, or CEA; PD-L1 ISAC utilizes a novel human anti-PD-L1 antibody conjugated to a next-generation TLR7/8 agonist payload via a non-cleavable linker; and BDC-3042, its dectin-2 agonist antibody program, developed to repolarize critical cells in the tumor microenvironment known as tumor associated macrophages. It operates in single segment.

About BTTC Black Titan Corporation Ordinary Shares

Black Titan Corp provides human resource and payroll consulting, software implementation, and training solutions using PeopleSoft platforms. The company's revenue is mainly derived from the provision of HCM solutions, followed by the provision of IT staff augmentation, outsourcing and consulting services.

Share on Social Networks: